Dent DiseaseSymptoms, Doctors, Treatments, Advances & More
Dent Disease Overview
Learn About Dent Disease
Dent disease is a chronic kidney disorder that occurs almost exclusively in males. The kidney problems seen in affected individuals are a result of damage to structures called proximal tubules. These structures help reabsorb water, protein, and other nutrients into the bloodstream or release them into the urine.
Changes in the CLCN5 gene cause Dent disease 1, while changes in the OCRL gene cause Dent disease 2. Genetic changes that cause disease are called pathogenic variants. Approximately 60 percent of people with Dent disease have type 1. Another 15 to 20 percent of people with Dent disease have type 2.
Approximately 850 families with Dent disease have been reported in the scientific literature. However, because the features of Dent disease can vary and may overlap with those seen in other disorders, this number may not accurately represent the number of people with this condition.
Dent disease is inherited in an X-linked pattern. The CLCN5 and OCRL genes are located on the X chromosome, which is one of the two sex chromosomes in each cell. In males (who have only one X chromosome), a pathogenic variant in the only copy of the gene in each cell is typically sufficient to cause the condition. This is not always the case for X-linked disorders in females (who have two X chromosomes in each cell). However, some females with a pathogenic variant in the CLCN5 or OCRL gene have mild features of Dent disease, including LMW proteinuria, hypercalciuria, and nephrolithiasis. Kidney failure in females is extremely rare. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.
Franca Anglani practices in Padova, Italy. Ms. Anglani is rated as an Elite expert by MediFind in the treatment of Dent Disease. Her top areas of expertise are Dent Disease, Nephrocalcinosis, Freeman Sheldon Syndrome, and Lowe Syndrome.
Stephane Lourdel practices in Paris, France. Ms. Lourdel is rated as an Elite expert by MediFind in the treatment of Dent Disease. Her top areas of expertise are Dent Disease, Bartter Syndrome, Hyperaldosteronism, and Nephrocalcinosis.
Mayo Clinic-Rochester
John Lieske is a Nephrologist in Rochester, Minnesota. Dr. Lieske is rated as an Elite provider by MediFind in the treatment of Dent Disease. His top areas of expertise are Kidney Stones, Nephrocalcinosis, Primary Hyperoxaluria, Kidney Transplant, and Lithotripsy.
Summary: The design is a single blinded, dual comparative study of ultrasound versus micro-CT/LASCA in one study group. Up to a total of 140 subjects registered will be recruited. Subjects who are treatment planned for extraction of a hopeless tooth and socket augmentation with bone graft and are planned for a dental implant surgery. The socket will be evaluated before the extraction and multi-time points ...
Summary: The purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria, Dent disease and adenine phosphoribosyltransferase deficiency (APRTd) and acquired enteric hyperoxaluria (EH). The investigator will measure blood and urinary markers of inflammation and determine relationship to the dise...
Published Date: April 10, 2026
Published By: National Institutes of Health